川芎嗪、丹参、银杏达莫注射液治疗糖尿病肾病的探讨

目的:探讨川芎嗪、丹参、银杏达莫注射液组合治疗糖尿病性微量白蛋白尿的疗效.方法:75例住院治疗的2型糖尿病患者随机分成丹参组(n=35)和银杏组(n=45),分别接受川芎嗪注射液160 mg 丹参注射液20 mL和川芎嗪注射液160mg 银杏达莫注射液20 mL,每日静滴1次,连续14日的治疗.在治疗前、后采集血、尿标本,测定血糖各项、血脂各项、肾功能和尿微量白蛋白等,并进行统计学分析处理.结果:治疗前,丹参组的甘油三脂和胆固醇脂较银杏组显著地升高(均P＜0.05),年龄、病程、血压、BMI、血糖各项、肾功能和尿微量白蛋白排泄量等指标,组间比较无显著性差异;治疗后,丹参组与银杏组的血糖均显著下降(均P＜0.01),丹参组的尿微量白蛋白排泄量未减少,银杏组的则显著的减少(P＜0.01),组间比较有显著性差异(P＜0.01).结论:川芎嗪与丹参注射液可能组合不当,不能减少尿微量白蛋白排泄量,川芎嗪与银杏达莫注射液组合能显著地减少尿微量白蛋白排泄量.

Effect of LHI, SMI and GDI in treating diabetic nephropathy

AIM: To investigate the therapeutic effect of Ligustrazine Hydrochloride Injection(LHI) plus Salvia miltiorrhiza Injection(SMI) and LHI plus Ginkgo leaf extract and Dipydamole Injection(GDI) in treating diabetic microalbuminuria. METHODS: 75 inpatients were randomly divided into group SMI(n=35) and group GDI(n=40).Group SMI was treated with LHI 160 mg plus SMI 20 mL intravenous drip daily for 14 days and group GDI with LHI 160 mg plus GDI 20 mL.Their blood samples were collected for measuring glucose,insulin,HbA1c,lipid,creatine and uroacid, and their urine samples for measuring microalbuminuria before and after treatment.The results were statistically(analyzed.)(RESULTS: Before)(treatment,) triglyceride and cholesterol concentrationincreased significantly in group SMI than in group GDI(all P<0.05).There was rarely difference between two groups in ages,course of diabetes,BMI,blood pressure,glucose,insulin,HbA1c,creatine,uroacid and microalbuminuria.After treatment,the plasma glucose concentration receded significantly in two groups(all P<(0.01)).The amount of excreting microalbuminuria in group SMI was unchanged significantly, but in group GDI was significantly decreased comparing with before treatment(P<0.01).In group GDI,the amount of excreting microalbuminuria decreased significantly than in group SMI(P<0.01). CONCLUSION: LHI plus SMI decrease rarely the amount of excreting microalbuminuria,because there may be incompatibility between LHI and SMI.LHI plus GDI can decrease significantly the amount of excreting microalbuminuria in diabetes.